What we're reading, September 26, 2016: the obesity rate in America has been rising steadily, but the health system is ill equipped to treat these patients; the pros and cons of mail-order medications; and barring recipients of federal funding from preventing money from going to Planned Parenthood.
The obesity rate in America has been growing steadily for 2 decades, but the health system remains ill equipped to treat overweight and obese patients. According to The New York Times, a lack of machines built big enough to service obese patients, drug doses that aren’t calibrated properly, and other difficulties mean obese patients often receive worse care than patients who are not overweight or obese. In addition, most doctors are reluctant to look beyond weight when it comes to diagnosing health problems.
Mail-order medications may have a number of benefits, but getting prescriptions through the mail may not be well suited to all medications. Convenience is a driver for mail-order prescriptions, but savings are not guaranteed and not all medications should be mail ordered, according to The Washington Post. Mail programs are ideal for drugs used on an ongoing basis that will be taken at a set dosage for a long time. However, issues can arise when a dosage changes, generics may not always be available right away, and certain drugs have shipping restrictions.
A proposal from the Obama administration would prevent recipients of federal family planning grants from preventing the money from going to Planned Parenthood. The Associated Press reported that the changes to the Title X grant program would bar recipients from placing their own eligibility restrictions on where the money can go. The program was designed to provide contraception services, screening and treatment for sexually transmitted diseases, and other services to low-income patients. It only pays for abortion in cases of rape, incest, or if the mother’s life is in danger.
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Provisional CDC data show that US babies gained roughly a year in life expectancy in 2022; study findings indicate that the COVID-19 pandemic significantly raised the risk of preterm birth for expectant California mothers; New York Attorney General Letitia James said about 4 million New Yorkers were affected by a data breach of the medical transcription company Perry Johnson & Associates.
Read More
A Look at Racial Disparities in US HPV Vaccine Uptake
March 1st 2022On this episode of Managed Care Cast, Leslie Cofie, PhD, MPH, an assistant professor of health education and promotion at the College of Health and Human Performance, East Carolina University, discusses his work on identifying and addressing racial disparities in human papillomavirus (HPV) vaccine uptake in the United States.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More